Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
4,827
Price
$2.26
Total Value
$10.91K
Shares Held After
361,827
% of Holdings
1.3%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
3,476
Price
$2.26
Total Value
$7.86K
Shares Held After
366,654
% of Holdings
0.9%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
2,224
Price
$2.26
Total Value
$5.03K
Shares Held After
370,130
% of Holdings
0.6%

Pulmonx Corp (LUNG)

Lehman David Aaron — General Counsel
Sep 1, 2026
Sale
Shares
3,807
Price
$2.26
Total Value
$8.60K
Shares Held After
372,354
% of Holdings
1.0%

American Well Corp (AMWL)

HIRSCHHORN MARK — Chief Financial Officer
Sep 1, 2026
Sale
Shares
10,751
Price
$11.80
Total Value
$126.86K
Shares Held After
228,188
% of Holdings
4.5%

American Well Corp (AMWL)

Gotlib Phyllis — President, International
Sep 1, 2026
Sale
Shares
3,573
Price
$11.80
Total Value
$42.16K
Shares Held After
149,181
% of Holdings
2.3%

BeOne Medicines Ltd. (ONC)

Ball Titus B. — Principal Accounting Officer
Sep 1, 2026
Sale
Shares
132
Price
$355.86
Total Value
$46.97K
Shares Held After
0
% of Holdings
100.0%

American Well Corp (AMWL)

McNeice Paul Francis — Chief Accounting Officer
Sep 1, 2026
Sale
Shares
112
Price
$11.80
Total Value
$1.32K
Shares Held After
9,739
% of Holdings
1.1%
Sep 1, 2026
Sale
Shares
10,000
Price
$242.72
Total Value
$2.43M
Shares Held After
122,423
% of Holdings
7.6%

Orthofix Medical Inc. (OFIX)

Fisher Patrick — President, Global Limb Recon
Sep 1, 2026
Sale
Shares
150
Price
$9.39
Total Value
$1.41K
Shares Held After
51,069
% of Holdings
0.3%

Moderna, Inc. (MRNA)

Klinger Shannon Thyme — Chief Legal Officer
Sep 1, 2026
Sale
Shares
3,471
Price
$139.95
Total Value
$485.77K
Shares Held After
74,129
% of Holdings
4.5%
Sep 1, 2026
Sale
Shares
35,769
Price
$3.12
Total Value
$111.57K
Shares Held After
11,563,425
% of Holdings
0.3%
Sep 1, 2026
Purchase
Shares
1,790
Price
$4.57
Total Value
$8.18K
Shares Held After
2,244
% of Holdings
79.8%

Maze Therapeutics, Inc. (MAZE)

Bernstein Harold — President, R&D&CMO
Sep 1, 2026
Sale
Shares
16,141
Price
$26.36
Total Value
$425.51K
Shares Held After
0
% of Holdings
100.0%
Sep 1, 2026
Sale
Shares
13,309
Price
$106.74
Total Value
$1.42M
Shares Held After
4,000
% of Holdings
76.9%
Sep 1, 2026
Sale
Shares
7,215
Price
$106.25
Total Value
$766.59K
Shares Held After
17,309
% of Holdings
29.4%
Sep 1, 2026
Sale
Shares
2,600
Price
$105.19
Total Value
$273.49K
Shares Held After
24,524
% of Holdings
9.6%

Liquidia Corp (LQDA)

Krepp Sarah — Chief Human Resource Officer
Sep 1, 2026
Sale
Shares
274
Price
$67.76
Total Value
$18.57K
Shares Held After
117,308
% of Holdings
0.2%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Sep 1, 2026
Sale
Shares
1,600
Price
$31.06
Total Value
$49.69K
Shares Held After
20,110
% of Holdings
7.4%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Sep 1, 2026
Sale
Shares
3,945
Price
$30.51
Total Value
$120.37K
Shares Held After
21,710
% of Holdings
15.4%

Denali Therapeutics Inc. (DNLI)

Schuth Alexander O. — COFO and Secretary
Sep 1, 2026
Sale
Shares
2,768
Price
$23.44
Total Value
$64.88K
Shares Held After
278,995
% of Holdings
1.0%
Sep 1, 2026
Purchase
Shares
783
Price
$69.52
Total Value
$54.43K
Shares Held After
526,000
% of Holdings
0.1%
Sep 1, 2026
Sale
Shares
2,000
Price
$26.33
Total Value
$52.66K
Shares Held After
27,923
% of Holdings
6.7%

Tempus AI, Inc. (TEM)

Fukushima Ryan — CEO, Data
Sep 1, 2026
Sale
Shares
1,000
Price
$64.63
Total Value
$64.63K
Shares Held After
16,574
% of Holdings
5.7%

Tempus AI, Inc. (TEM)

Fukushima Ryan — CEO, Data
Sep 1, 2026
Sale
Shares
5,900
Price
$63.80
Total Value
$376.42K
Shares Held After
17,574
% of Holdings
25.1%

Tempus AI, Inc. (TEM)

Fukushima Ryan — CEO, Data
Sep 1, 2026
Sale
Shares
10,900
Price
$62.64
Total Value
$682.78K
Shares Held After
23,474
% of Holdings
31.7%

Tempus AI, Inc. (TEM)

Fukushima Ryan — CEO, Data
Sep 1, 2026
Sale
Shares
13,046
Price
$62.12
Total Value
$810.42K
Shares Held After
34,374
% of Holdings
27.5%

PULSE BIOSCIENCES, INC. (PLSE)

Teplitsky Liane Rae — Chief Operating Officer
Sep 1, 2026
Purchase
Shares
1,001
Price
$49.95
Total Value
$50.00K
Shares Held After
4,095
% of Holdings
24.4%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Sep 1, 2026
Sale
Shares
303
Price
$61.42
Total Value
$18.61K
Shares Held After
155,041
% of Holdings
0.2%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Sep 1, 2026
Sale
Shares
924
Price
$60.95
Total Value
$56.32K
Shares Held After
155,344
% of Holdings
0.6%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Sep 1, 2026
Sale
Shares
713
Price
$61.48
Total Value
$43.84K
Shares Held After
156,268
% of Holdings
0.5%

Vaxcyte, Inc. (PCVX)

Wassil Jim — CHIEF OPERATING OFFICER
Sep 1, 2026
Sale
Shares
1,537
Price
$60.89
Total Value
$93.58K
Shares Held After
156,981
% of Holdings
1.0%
Sep 1, 2026
Purchase
Shares
2,098
Price
$5.53
Total Value
$11.60K
Shares Held After
10,708
% of Holdings
19.6%
Sep 1, 2026
Sale
Shares
30,000
Price
$3.34
Total Value
$100.20K
Shares Held After
6,158,287
% of Holdings
0.5%

EXAGEN INC. (XGN)

Black Jeffrey G. — Chief Financial Officer
Sep 1, 2026
Sale
Shares
20,614
Price
$7.22
Total Value
$148.78K
Shares Held After
323,339
% of Holdings
6.0%
Sep 1, 2026
Purchase
Shares
179,058
Price
$1.80
Total Value
$321.57K
Shares Held After
5,436,447
% of Holdings
3.3%
Sep 1, 2026
Sale
Shares
6,000
Price
$250.13
Total Value
$1.50M
Shares Held After
351,875
% of Holdings
1.7%
Sep 1, 2026
Purchase
Shares
248,000
Price
$0.52
Total Value
$128.71K
Shares Held After
4,723,148
% of Holdings
5.3%

Cencora, Inc. (COR)

Krikorian Lazarus — SVP&Chief Accounting Officer
Sep 1, 2026
Sale
Shares
985
Price
$325.97
Total Value
$321.08K
Shares Held After
16,169
% of Holdings
5.7%

Karyopharm Therapeutics Inc. (KPTI)

Abate Kristin — Chief Accounting Officer
Sep 1, 2026
Sale
Shares
19
Price
$2.02
Total Value
$38.38
Shares Held After
23,782
% of Holdings
0.1%
Sep 1, 2026
Purchase
Shares
525
Price
$12.62
Total Value
$6.63K
Shares Held After
525
% of Holdings
100.0%
Sep 1, 2026
Sale
Shares
525
Price
$12.72
Total Value
$6.68K
Shares Held After
0
% of Holdings
100.0%
Sep 1, 2026
Sale
Shares
5,408
Price
$149.38
Total Value
$807.86K
Shares Held After
577,133
% of Holdings
0.9%
Sep 1, 2026
Sale
Shares
7,992
Price
$148.36
Total Value
$1.19M
Shares Held After
582,541
% of Holdings
1.4%
Sep 1, 2026
Sale
Shares
1,600
Price
$147.51
Total Value
$236.01K
Shares Held After
590,533
% of Holdings
0.3%
Sep 1, 2026
Sale
Shares
15,000
Price
$4.94
Total Value
$74.10K
Shares Held After
1,134,402
% of Holdings
1.3%
Sep 1, 2026
Sale
Shares
97,581
Price
$38.42
Total Value
$3.75M
Shares Held After
100,373
% of Holdings
49.3%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Sep 1, 2026
Sale
Shares
9,000
Price
$46.99
Total Value
$422.87K
Shares Held After
65,389
% of Holdings
12.1%
Sep 1, 2026
Sale
Shares
4,800
Price
$92.44
Total Value
$443.69K
Shares Held After
925,580
% of Holdings
0.5%
Sep 1, 2026
Sale
Shares
63,596
Price
$91.90
Total Value
$5.84M
Shares Held After
930,380
% of Holdings
6.4%
Version: v26.10.6